← FDA Drug Approvals (Drugs@FDA)

LEVALBUTEROL HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NEPHRON · Approved 2026-05-26

Drug application

FDA Application #

ANDA215217

Application type

Abbreviated New Drug Application (Generic)

Brand name

LEVALBUTEROL HYDROCHLORIDE

Generic name

Levalbuterol Hydrochloride

Active ingredients

LEVALBUTEROL HYDROCHLORIDE

Dosage form

SOLUTION

Route

INHALATION

Marketing status

Prescription

Sponsor

NEPHRON

First approval

2026-05-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown